Chemours, DuPont, and Corteva have agreed to pay $875 million to settle claims related to PFAS contamination in New Jersey. These so-called "forever chemicals" have been linked to pollution concerns, with the settlement marking a notable resolution in ongoing environmental litigation. Separately, CureVac, Pfizer, and BioNTech have reached a settlement over mRNA vaccine patents, with CureVac receiving $740 million and GSK obtaining a non-exclusive U.S. license for COVID-19 and influenza products. GSK is also set to receive approximately $370 million from related U.S. patent litigation settlements. Additionally, the Washington Works site has been reported to violate permit limits by discharging elevated levels of PFAS into the Ohio River, which provides drinking water to around 5 million people.